Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Sep 14, 2026Reported sale · Form 4David P Meeker, President and CEO · $655.1KOpen the filing ↗
- Sep 14, 2026Reported sale · Form 4David P Meeker, President and CEO · $3.1MOpen the filing ↗
- Sep 14, 2026Reported sale · Form 4David P Meeker, President and CEO · $899.6KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record79619 flagged findings
Reported transactions (Form 4)80since Feb 11, 2026 · and 2 other holdings
Corporate events (8-K)30since Aug 9, 2018
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-05share offering or dilution eventrecentOpen filing ↗“…26, 2026, the Company filed with the SEC a registration statement on Form S-3ASR containing a base prospectus and a prospectus…”
+1 more passage from the same document
- “…26, 2026, pursuant to which issuances and sales under the Sales Agreement will be made. Between December 10, 2024 and December 31,…”
- 2026-05-05capital return (buybacks/dividends)recentOpen filing ↗“…Purchase Agreement”, and with the License Agreement the “RareStone Agreements”). Under the Termination Agreement, the Company…”
+1 more passage from the same document
- “…Purchase Agreement”, and with the License Agreement the “RareStone Agreements”). Under the Termination Agreement, the Company agreed…”
- 2026-05-05regulatory investigationrecentOpen filing ↗“…any ongoing clinical trials; • refuse to approve pending applications or supplements to applications submitted by us; • suspend or…”
+1 more passage from the same document
- “…Tricare Agreement, whether due to a misstated FCP or otherwise, we are required to refund the difference to the government. Failure…”
- 2026-05-05Department of Justice inquiryrecentOpen filing ↗“…Trade Commission Act. The FTC expects a company’s data security measures to be reasonable and appropriate in light of the…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 796)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 13, 26SCHEDULE 13G ↗Passive stake · JPMORGAN CHASE & CO. · 5.1% · event on Sep 30, 26 new
- Sep 14, 26Form 144 ↗Notice of proposed sale
- Aug 31, 26Form 144 ↗Notice of proposed sale
- Aug 18, 26Form 4 ↗Insider transaction
- Aug 18, 26Form 3 ↗Insider transaction
Notice of proposed sale · 6 Form 144 filingsshow all 6hide
- Aug 13, 26Form 144 ↗Notice of proposed sale
- Aug 13, 26Form 144 ↗Notice of proposed sale
- Aug 13, 26Form 144 ↗Notice of proposed sale
- Aug 12, 26Form 144 ↗Notice of proposed sale
- Aug 11, 26Form 144 ↗Notice of proposed sale
- Aug 10, 26Form 144 ↗Notice of proposed sale
- Aug 4, 2610-Q ↗Quarterly report
- Aug 4, 268-K ↗Current report · Results · Communication to the market · Other events
- Jul 2, 26Form 4 ↗Insider transaction
- Jun 25, 268-K ↗Current report · Shareholder vote results
796 filings on record, the oldest from Nov 10, 15.
Listing the 25 most recent filings of the 796 on record.
1615
- Apr 3, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Dec 19, 25A senior executive left or was appointed8-K 5.02 ↗
- Mar 20, 25A material agreement was terminated+2 more in the same filing8-K 1.02 ↗
4 material agreements entered2024show all 4hide
- Apr 16, 24Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- Apr 1, 24Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Feb 29, 24Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Jan 4, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Aug 8, 23A senior executive left or was appointed8-K 5.02 ↗
- Aug 3, 23A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Nov 3, 22A material agreement was terminated8-K 1.02 ↗
- Jun 16, 22Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Dec 8, 21Entered a material agreement8-K 1.01 ↗
3 senior executive changes2021show all 3hide
- Sep 2, 21A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Apr 23, 21A senior executive left or was appointed8-K 5.02 ↗
- Mar 16, 21A senior executive left or was appointed8-K 5.02 ↗
- Jan 5, 21Entered a material agreement+1 more in the same filing8-K 1.01 ↗
3 senior executive changes2020 – 2021show all 3hide
- Jan 4, 21A senior executive left or was appointed8-K/A 5.02 ↗
- Dec 11, 20A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Sep 16, 20A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
7 older filings not shown · The record reaches back to Apr 2, 18.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- RA Capital Management, L.P.9.9%Dec 31, 25SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- The Vanguard Group9.3%Dec 31, 25SCHEDULE 13G/A ↗1 earlier filing
- Baker Bros. Advisors LP8.9%Mar 31, 25SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- BlackRock, Inc.6.9%Mar 31, 25SCHEDULE 13G/A ↗
- PRIMECAP MANAGEMENT CO/CA/5.2%Dec 31, 25SCHEDULE 13G/A ↗3 earlier filings
show 3 more holdershide
- JPMORGAN CHASE & CO.5.1%Sep 30, 26SCHEDULE 13G ↗
- Perceptive Advisors LLC5.1%Mar 31, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Vanguard Capital Management5.0%Mar 31, 26SCHEDULE 13G ↗
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Sep 14, David Meeker filed notice of intent to sell up to $5.2M. That is about 0.07% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $5.1M across 5 trades on Sep 14, per their Form 4. That is 100% of the shares announced so far, and the window is still open.
View notice (Form 144) ↗+8 more recent notices · 6 with a later sale
- Sep 14, 26Sell$655KDavid P MeekerPresident and CEO↗
- Sep 14, 26Sell$3.1MDavid P MeekerPresident and CEO↗
- Sep 14, 26Sell$900KDavid P MeekerPresident and CEO↗
- Sep 14, 26Sell$190KDavid P MeekerPresident and CEO↗
- Sep 14, 26Sell$242KDavid P MeekerPresident and CEO↗
- Aug 31, 26Sell$2.4MHunter C SmithChief Financial Officer↗
- Aug 31, 26Sell$1.2MHunter C SmithChief Financial Officer↗
- Aug 31, 26Sell$3.0MHunter C SmithChief Financial Officer↗
- Aug 13, 26Sell$8.9MJennifer Kayden LeeEVP, Head of North America↗
- Aug 13, 26Sell$233KAlastair GarfieldChief Scientific Officer↗
- Aug 13, 26Sell$182KAlastair GarfieldChief Scientific Officer↗
- Aug 13, 26Sell$402KAlastair GarfieldChief Scientific Officer↗
There are 11 more transactions in this stretch.
Stock compensation, tax and giftsshow the 17 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Sep 14, 26Compensation$303KDavid P MeekerPresident and CEO↗
- Aug 31, 26Compensation$1.5MHunter C SmithChief Financial Officer↗
- Aug 13, 26Compensation$850KJennifer Kayden LeeEVP, Head of North America↗
- Aug 13, 26Compensation$147KJennifer Kayden LeeEVP, Head of North America↗
- Aug 13, 26Compensation$14KJoseph ShulmanChief Technical Officer↗
- Aug 12, 26Compensation$317KYann MazabraudEVP, Head of International↗
- Jul 1, 26Compensationamount n/aAlastair GarfieldChief Scientific Officer↗
- Jul 1, 26Tax$237KAlastair GarfieldChief Scientific Officer↗
- Jun 23, 26Compensationamount n/aDAVID W J MCGIRR↗
- Jun 22, 26Compensation$1.0MLYNN A. TETRAULT↗
- May 18, 26Compensation$54KHunter C SmithChief Financial Officer↗
- May 15, 26Compensation$96KChristopher Paul GermanCorporate Controller & CAO↗
- May 15, 26Compensation$66KChristopher Paul GermanCorporate Controller & CAO↗
- May 15, 26Compensation$25KChristopher Paul GermanCorporate Controller & CAO↗
- Apr 1, 26Compensationamount n/aYann MazabraudEVP, Head of International↗
- Mar 12, 26Otheramount n/aEdward T Mathers↗
- Mar 4, 26Compensation$27KChristopher Paul GermanCorporate Controller & CAO↗
The full record holds 398 transactions and goes back to Feb 1, 23.
Its sector and its market
Rhythm Pharmaceuticals Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Rhythm Pharmaceuticals Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Rhythm Pharmaceuticals Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 796 documents on file, from Nov 10, 2015 to Oct 13, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.